Medicared For All Logo

Kavita Kalra MD in Baltimore, Maryland

Home Maryland Baltimore

Kavita Kalra MD has Hematology/oncology as her primary medical specialty. Their primary office is: 821 N Eutaw St in Baltimore, Maryland. There is an additional office location, for a total of two, for Kavita Kalra MD that can be viewed further down. They attended Sorry, her university is not listed and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Kavita B Kalra MD Office Phone and Directions

Kavita Kalra MD
821 N Eutaw St
Baltimore, Maryland 21201
410-246-4450


Patient Ratings
Please rate your experience with Kavita Kalra MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 410-246-4450


Enter a starting address:


Healthcare Info for Kavita Kalra MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Kavita Kalra MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 9739113911
NPI #: 1063495232
NPI Created On: 11/22/2005
NPI Last Updated Listed as: 03/21/2016
Primary Taxonomy Code: 207RH0003X
License Number:
D58037
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • CareFirst BlueChoice, Inc.
  • Group Hospitalization and Medical Services Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  3. Infusion into a vein for therapy, prevention, or diagnosis
  4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  6. Infusion of chemotherapy into a vein up to 1 hour
  7. Infusion of chemotherapy into a vein
  8. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  9. New patient office or other outpatient visit, typically 20 minutes
  10. Established patient office or other outpatient visit, typically 5 minutes
  11. Established patient office or other outpatient visit, typically 10 minutes
  12. Established patient office or other outpatient visit, typically 15 minutes
  13. Established patient office or other outpatient, visit typically 25 minutes
  14. Injection, dexamethasone sodium phosphate, 1 mg
  15. Injection, diphenhydramine hcl, up to 50 mg
  16. Injection, infliximab, excludes biosimilar, 10 mg
  17. Injection, ocrelizumab, 1 mg
  18. Injection, ondansetron hydrochloride, per 1 mg
  19. Injection, ranitidine hydrochloride, 25 mg
  20. Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788986925

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $53

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788986923

Being Disputed:: No

Product Related: No


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790253589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Rubraca

Open Associated Drug #1: 69660-201-91


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011593

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011595

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795017613

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801729573

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: BENLYSTA

Open Associated Drug #1: 49401-101-01


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801731469

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802031319

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802389091

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Additional Office Locations

1.
3333 N Calver St
Baltimore, MD 21218
Suite 555
Group Members: 0

Phone: 410-246-4450

Enter a starting address:


Hematology/oncology Professionals in Baltimore

9000 Franklin Square Dr
Baltimore, MD
Medstar Medical Group Ii Llc

7602 Belair Rd
Baltimore, MD
Lutherville Hematology And Oncology Services

7602 Belair Rd
Baltimore, MD
Lutherville Hematology And Oncology Services

301 Saint Paul St
Baltimore, MD
St Paul Place Specialists Inc

7602 Belair Rd
Baltimore, MD
St Paul Place Specialists Inc

201 E University Pkwy
Baltimore, MD
Medstar Medical Group Ii Llc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry